Qiagen Clinical Insight
Qiagen has launched Qiagen Clinical Insight, a bioinformatics content and software platform that clinical testing laboratories can use to interpret and report on genomic variants identified in next-generation sequencing data.
According to the company, the Clinical Insight platform provides tools for evaluating genomic variants in the context of published biomedical literature, professional association guidelines, publicly available databases and annotations, drug labels, and clinical trials. It enables clinicians rapidly classify variants, identify treatment options, and match patients to clinical trials. It also provides access to the Allele Frequency Community, a large repository of ancestral and ethnic diversity data.
The platform currently supports somatic and hereditary cancer testing.
Waters has launched the Vion IMS QTof Mass Spectrometer. The benchtop tandem mass spec instrument features ion mobility to remove spectral interferences and generate collision cross-section values for every ion, giving scientists more information than they can get from traditional LC-MS experiments, the company said. The platform also features the REIMS Research System with iKnife sampling, combining direct-from-sample ionization with high-performance time-of-flight mass spectrometry.
Waters also introduced the Oasis PRiME HLB next-generation solid phase extraction product, designed to provide cleaner samples in less time and with less effort for LC and LC-MS analyses. Laboratories can now process samples up to 40 percent faster and deliver samples that are up to 70 percent cleaner with fewer LC-MS matrix effects than samples prepared using other extraction techniques, the company said.